The Bombay Stock Exchange (BSE) has included drug maker Cipla in its benchmark 30 share index Sensex by replacing rival Sun Pharmaceuticals. The change will come into effect from May 3, the exchange said in a statement on Saturday. It also revised changes in its other indexes like BSE 100, BSE 200 and BSE 500. The changes will come into effect from March 29.
Top Section
Explore Business Standard